Assessment of response to preoperative chemotherapy in patients with stage II and III breast cancer: the value of MRI
- 31 August 2002
- journal article
- Published by Elsevier in The Breast
- Vol. 11 (4) , 306-315
- https://doi.org/10.1054/brst.2002.0450
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Neoadjuvant chemotherapy for breast cancerAnnals of Medicine, 2000
- Breast Carcinoma: Effect of Preoperative Contrast-enhanced MR Imaging on the Therapeutic ApproachRadiology, 1999
- Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant ChemotherapyJournal of Clinical Oncology, 1999
- Utility of Magnetic Resonance Imaging in the Management of Breast Cancer: Evidence for Improved Preoperative StagingJournal of Clinical Oncology, 1999
- Primary chemotherapy: A better overall therapeutic option for patients with breast cancerAnnals of Oncology, 1998
- A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancerAnnals of Oncology, 1998
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.Journal of Clinical Oncology, 1998
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imagingThe American Journal of Surgery, 1993